Paul Goepfert, MD, Infectious Disease, Birmingham, AL, Birmingham Veterans Affairs Medical Center

PaulAGoepfertMD

Infectious Disease Birmingham, AL

Professor, Medicine, University of Alabama School of Medicine

Dr. Goepfert is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Goepfert's full profile

Already have an account?

Education & Training

  • University of Alabama Medical Center
    University of Alabama Medical CenterFellowship, Infectious Disease, 1994 - 1997
  • University of Alabama Medical Center
    University of Alabama Medical CenterResidency, Internal Medicine, 1991 - 1994
  • Baylor College of Medicine
    Baylor College of MedicineClass of 1991

Certifications & Licensure

  • AL State Medical License
    AL State Medical License 1992 - 2021
  • TX State Medical License
    TX State Medical License 1992 - 1997
  • American Board of Internal Medicine Infectious Disease

Awards, Honors, & Recognition

  • Elected Member The American Society for Clinical Investigation, 2010

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Johnson & Johnson's COVID-19 Vaccine Results Are Better Than They May Sound
    Johnson & Johnson's COVID-19 Vaccine Results Are Better Than They May SoundJanuary 30, 2021 16:33
  • COVID-19 Vaccine Facts and Figures
    COVID-19 Vaccine Facts and FiguresJanuary 28, 2021 17:44
  • NIH’s Strategy to Assess Moderna’s COVID-19 Vaccine at Half Dose Has Significant Stumbling Blocks for Evidence Collection and Analysis
    NIH’s Strategy to Assess Moderna’s COVID-19 Vaccine at Half Dose Has Significant Stumbling Blocks for Evidence Collection and AnalysisJanuary 24, 2021 11:37
  • Join now to see all

Grant Support

  • CTL And HIV Polymorphisms In Heterosexual TransmissionNational Institute Of Allergy And Infectious Diseases2010–2012
  • HIV-1 Cryptic Epitopes: Implications For Vaccine DesignNational Institute Of Allergy And Infectious Diseases2009–2011
  • ClinicalNational Institute Of Allergy And Infectious Diseases2008–2011
  • HIV-1 Suppression By MHC Class I Restricted CD8 T CellsNational Institute Of Allergy And Infectious Diseases2007–2008
  • Alabama/Zambia HIV Vaccine Clinical Trials Unit (HVTU)National Institute Of Allergy And Infectious Diseases2004–2006
  • CD8+ T Cell Cytokine Production In HIV-1 InfectionNational Institute Of Allergy And Infectious Diseases2002–2005
  • CD8+ T Cell Cytokine Production In HIV-1 InfectionNational Institute Of Allergy And Infectious Diseases2001
  • Human Foamy Virus Structural ProteinsNational Institute Of Allergy And Infectious Diseases1996–2000

Hospital Affiliations